SUNDAY, JUNE 25, 2017

Outdated practices stall drug-resistant TB fight

Leaders from Doctors Without Borders (MSF) and the Stop TB Partnership recently published the second part of the report titled "Out of Step," which was previously an outdated resource that allowed drug-resistant tuberculosis (TB) to continue spreading. Read More »

WHO releases resource for African adolescents with HIV

In honor of World AIDS Day on Dec. 1, the World Health Organization (WHO) published new guidelines that will help adolescents in Africa better understand their HIV infections and their special needs. Read More »

Reduced HIV treatment costs allows UN to expand efforts

The United Nations Development Program (UNDP) has made significant decreases in the cost of HIV treatments, which has benefited patients in Equatorial Guinea, Haiti, Mali, South Sudan, Zambia and Zimbabwe. Read More »

Shortage of treatments counteract HIV efforts in Africa

Doctors Without Borders (MSF) recently stated that efforts to eliminate HIV in sub-Saharan Africa have been damaged by shortages of antiretroviral medicines needed for treatments. Read More »

Doctors Without Borders encourages WHO guidelines for HIV/AIDS treatment

Doctors Without Borders (MSF) issued a statement last week urging that World Health Organization (WHO) guidelines for testing and treating HIV and AIDS patients be taken up globally. Read More »

South Sudan communities support Doctors Without Borders in malaria fight

Doctors Without Borders (MSF) has been grateful for the help of local communities throughout South Sudan in fighting the recent increase in malaria cases. Read More »

University of Rochester tests novel method for HIV prevention

Researchers at New York's University of Rochester Medical Center recently began testing a new approach to preventing HIV infections. Read More »

AIDS research journal explores PrEP prevention methods

AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert Inc., recently featured articles about the use of emerging biomedical pre-exposure prophylaxis (PrEP) to prevent HIV infections. Read More »

Kenya, Nigeria receive grants to improve health services

Kenya and Nigeria recently received grants from the Institute of Human Virology (IHV) to improve laboratory services based in Kenya and improve the biosecurity infrastructure based in Nigeria. Read More »

Iran's malaria health services available to seasonal workers

Iran provides malaria diagnosis, treatment and care services to people without any cost. Read More »

Zithromax donations aid in fight against trachoma

Pfizer Inc., the International Trachoma Initiative, and the ICTC have donated the 500 millionth dose of Zithromax. Read More »

Groups strive to meet demands for HIV counseling and testing in Nigeria

Nigeria has second highest number of new HIV infections in world. Read More »

Computer model outlines spread of Ebola

Analysts recently created a computer model that outlines how the Ebola outbreak spread, which may help researchers anticipate the spread of the disease in the future. Read More »

Patent dispute in South Africa limits access to HIV medicine

Health professionals have called for leaders in South Africa to override patents to stop the widespread stock shortage of HIV medicine as doctors have been forced to send patients home without drugs because the pharmaceutical company AbbVie refuses to provide a license for generic manufacture. Read More »

Doctors Without Borders awaits further tests on malaria vaccine

Despite recommendations from the World Health Organization (WHO), Doctors Without Borders (known by its French acronym MSF) has not launched promotions for the use of RTS,S as a malaria vaccine. Read More »

Nebraska researchers advance experimental treatment for HIV

Scientists from the University of Nebraska Medical Center have created a delivery system for drugs that can eliminate HIV from immune cells and maintain control over the virus for lengthy amounts of time. Read More »

GSK, Pfizer finalize meningitis assets transaction

GlaxoSmithKline (GSK) and Pfizer recently announced that they have successfully finalized their transaction of Nimenrix and Mencevax, both of which are meningitis assets. Read More »

Doctors Without Borders praises WHO for new HIV antiretroviral 'treat all' stance

The World Health Organization recently established new guidelines recommending that all patients testing positive for HIV be offered immediate antiretroviral treatment, a move that was cheered by international medical humanitarian organization Médecins Sans Frontières/Doctors Without Borders (MSF). Read More »

University of Rochester receives funding for HIV vaccine development

University of Rochester School of Medicine and Dentistry researchers specializing in infectious diseases recently received $3.1 million to discover new methods of developing HIV vaccines. Read More »

MSF, UNICEF conduct mass malaria treatment campaign in South Sudan

Over the past seven weeks, UNICEF and MSF (Doctors Without Borders) have treated approximately 16,000 people in their mass malaria treatment campaign in South Sudan. Read More »